CrushSCI.com
提供学术论文选刊润色服务
Targeted Oncology 期刊封面 医学
返回期刊列表

Review Cycle Records

Targeted Oncology

Springer SCIE 非OA
2026新锐 2区2025中科院 3区2025 JCR Q2
83.9平均天数
75中位天数
31最短天数
165最长天数
712025发文量

Paper Review Records

全部论文审稿周期

10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

45 天

Precision Medicine in Pancreatic Cancer: Targeting KRAS and Beyond

作者Hendrik Schürmann; Wungki Park; Grainne M. O’Kane; Carolina Sciortino; Monica Niger; Maximilian Reichert; Kenneth P. Olive; Ina Pretzell; C. Benedikt Westphalen

作者单位1. Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; 2. Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Translational Oncology (DKTK), West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; 3. German Cancer Consortium (DKTK), Partner Site Essen, a Partnership Between German Cancer Research Center (DKFZ) and University Hospital Essen, Essen, Germany; 4. Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; 5. Weill Cornell Medical College, New York, USA; 6. David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, USA; 7. St. Vincent’s University Hospital and School of Medicine, University College Dublin, Dublin, Republic of Ireland; 8. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 9. Center for Translational Pancreatic Cancer Research, TUM School of Medicine and Health, Department of Clinical Medicine, Clinical Department for Internal Medicine II, TUM University Hospital, Technical University of Munich, Munich, Germany; 10. Center for Organoid Systems (COS), Munich Institute of Biomedical Engineering (MIBE), Technical University Munich (TUM), Garching, Germany; 11. German Cancer Consortium (DKTK), Partner Site Munich, A Partnership Between German Cancer Research Center (DKFZ) and TUM University Hospital, Munich, Germany; 12. Bavarian Cancer Research Center (BZKF), Munich, Germany; 13. Department of Medicine, Division of Digestive and Liver Diseases, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, USA; 14. Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, USA; 15. West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; 16. Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; 17. German Cancer Consortium (DKTK), Partner Site Munich, a Partnership Between German Cancer Research Center (DKFZ) and University Hospital of the LMU Munich, Munich, Germany; 18. Comprehensive Cancer Center (CCC Munich LMU), LMU University Hospital Munich, Munich, Germany

PDF源文件 DOI 网页
105 天

From Recommendation to Implementation: Clinical Outcomes of a Single-Center Molecular Tumor Board

作者Tabea Fröhlich; Ulrich Lehmann; Tanja Reineke-Plaaß; Thomas Wirth; Sabrina Welland; Chen Du; Bernd Auber; Benjamin-Alexander Bollmann; Philipp Ivanyi; Tjoung-Won Park-Simon; Diana Steinmann; Christian Hartmann; Ariana de Oliviera Mekonnen; Anja Heutling; Andrea Schütte; Hans Heinrich Wedemeyer; Florian Heinrich Heidel; Susanne Isfort; Arndt Vogel; Anna Saborowski

作者单位1. Center for Personalized Medicine (Zentrum für Personalisierte Medizin, ZPM), Comprehensive Cancer Center (CCC) Hannover (Claudia von Schilling Center), Hannover Medical School, Hannover, Germany; 2. Department of Hematology, Hemostasis, Oncology and Cell Therapy, Hannover Medical School, Hannover, Germany; 3. PRACTIS Clinician Scientist Program, Dean’s Office for Academic Career Development, Hannover Medical School, Hannover, Germany; 4. Institute of Pathology, Hannover Medical School, Hannover, Germany; 5. Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany; 6. Institute of Human Genetics, Hannover Medical School, Hannover, Germany; 7. Department of Pneumology and Infectious Diseases, Hannover Medical School, Hannover, Germany; 8. Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany; 9. Department of Radiation Oncology and Special Oncology, Hannover Medical School, Hannover, Germany; 10. Department of Neuropathology, Institute of Pathology, Hannover Medical School, Hannover, Germany; 11. Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany; 12. Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, Schwartz Reisman Liver Research Centre, Toronto, Canada

PDF源文件 DOI 网页
39 天

Real-World Treatment Patterns in Advanced Cutaneous Melanoma in the USA

作者Matthew S. Block; Ashley E. Stenzel; Rene Marcotte; Katrine L. Wallace

作者单位1. Mayo Clinic, Comprehensive Cancer Center, Rochester, USA; 2. Replimune Inc, Woburn, USA; 3. RCM Consulting, Attleboro, USA; 4. University of Illinois Chicago, School of Public Health, Chicago, USA

PDF源文件 DOI 网页
134 天

Efficacy and Safety Differences Between Abiraterone and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis of Real-World Studies

作者Anikó Katalin Valikovics; Dániel Bacsó; Nadeen Samaien; Isabel Pinto Amorim das Virgens; Boglárka Szentes; Gergely Agócs; Mahmoud Obeidat; Tamás Széll; Boris Hadaschik; Péter Hegyi; Péter Nyirády; Tibor Szarvas

作者单位1. Centre for Translational Medicine, Semmelweis University, Budapest, Hungary; 2. Department of Urology, Semmelweis University, Budapest, Hungary; 3. Department of Urology, University of Duisburg-Essen and German Cancer Consortium, Essen, Germany; 4. Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary; 5. Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary

PDF源文件 DOI 网页
74 天

Chimeric Antigen Receptor-T Cell Therapy for Pediatric and Young Adult Primary Central Nervous System Tumors: A Systematic Review of Early Phase Clinical Trials with a Focus on Diffuse Midline Glioma

作者Sai Sanikommu; Alejandro N. Santos; Bashar Dawoud; Khushi H. Shah; Sima Vazquez; Ashish H. Shah; Victor M. Lu

作者单位1. Department of Neurosurgery, Miller School of Medicine, University of Miami, Miami, USA

PDF源文件 DOI 网页
70 天

Afatinib Versus Osimertinib as First-Line Treatment for Advanced EGFR -Mutant Non-Small-Cell Lung Cancer: A 3-Year Follow-Up Overall Survival Analysis

作者Yen-Hsiang Huang; Kuo-Hsuan Hsu; Jeng-Sen Tseng; Po-Hsin Lee; I-Hung Lin; Mu-Han Peng; Tsung-Ying Yang

作者单位1. Department of Chest Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; 2. Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital, Taichung, Taiwan; 3. School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; 4. Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan; 5. Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan; 6. Doctoral Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan; 7. Rong Hsing Translational Medicine Research Center, National Chung Hsing University, Taichung, Taiwan

PDF源文件 DOI 网页
76 天

Real-World Outcomes of Adjuvant Pembrolizumab for Renal Cell Carcinoma: The Potential Role of PD-L1 as a Prognostic Biomarker

作者Hiroki Ishihara; Takayuki Nakayama; Hironori Fukuda; Nanaka Katsurayama; Yuki Nemoto; Shinsuke Mizoguchi; Hiroaki Shimmura; Yasunobu Hashimoto; Atsuko Seki; Kazuhiko Yoshida; Junpei Iizuka; Tsunenori Kondo; Yoji Nagashima; Toshio Takagi

作者单位1. Department of Urology, Saiseikai Kawaguchi General Hospital, Kawaguchi, Japan; 2. Department of Urology, Tokyo Women’s Medical University, Tokyo, Japan; 3. Department of Urology, Tokyo Women’s Medical University Adachi Medical Center, Tokyo, Japan; 4. Department of Urology, Jyoban Hospital, Iwaki, Japan; 5. Department of Urology, Saiseikai Kazo Hospital, Kazo, Japan

PDF源文件 DOI 网页
31 天

Should Metastatic Site Inform First-Line Therapy in Clear Cell Renal Cell Carcinoma?

作者Michael A. Liu; Kyle Miyazaki; Karie Runcie; Hanna Cash; Lingbin Meng

作者单位1. Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA; 2. Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, USA; 3. Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USA

PDF源文件 DOI 网页
100 天

Real-World Comparative Effectiveness and Safety of Immune Checkpoint Inhibitors in Advanced Renal Cell Carcinoma: A Systematic Review

作者Chin Hang Yiu; Gwyneth Yuet Yin Leung; Isabelle C. Lee; Christine Y. Lu

作者单位1. The University of Sydney, School of Pharmacy, Camperdown, Australia; 2. Kolling Institute, Faculty of Medicine and Health, The University of Sydney and the Northern Sydney Local Health District, Sydney, Australia; 3. Department of Pharmacy, Royal North Shore Hospital, St Leonards, Australia

PDF源文件 DOI 网页
165 天

Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial

作者Yu Sunakawa; Hisateru Yasui; Manabu Shiozawa; Hiroyuki Takeda; Naoya Akazawa; Tamotsu Sagawa; Kazuhiro Shiraishi; Takahisa Kyogoku; Takashi Mine; Yasuhiro Yuasa; Takanori Watanabe; Tatsuya Kinjo; Yoshihiro Okita; Hiroyuki Okuyama; Satoshi Yuki; Koki Miyakawa; Ayana Kobara; Shoko Yanaka; Yukiko Abe; Wataru Ichikawa; Masashi Fujii; Akihito Tsuji

作者单位1. Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan; 2. Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan; 3. Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan; 4. Department of Gastroenterological Surgery, Sendai City Medical Center Sendai Open Hospital, Sendai, Japan; 5. Department of Gastroenterology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan; 6. Department of Medical Oncology, NHO Nagoya Medical Center, Nagoya, Japan; 7. Department of Surgery, Kobe City Nishi-Kobe Medical Center, Kobe, Japan; 8. Department of Clinical Oncology, Nagasaki Harbor Medical Center, Nagasaki, Japan; 9. Department of Gastrointestinal Surgery, Tokushima Red Cross Hospital, Tokushima, Japan; 10. Department of Surgery, Japanese Red Cross Society Himeji Hospital, Himeji, Japan; 11. Department of Surgery, Tokushima Municipal Hospital, Tokushima, Japan; 12. Division of Digestive and General Surgery, University of the Ryukyus, Ginowan, Japan; 13. Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan; 14. Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan; 15. Sysmex Corporation, Kobe, Japan; 16. G&G SCIENCE CO., LTD., Fukushima, Japan; 17. Division of Medical Oncology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan; 18. Japan Clinical Cancer Research Organization, Tokyo, Japan

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。